DanielAvramOrringerMDFAANS
Neurosurgery • New York, NYBrain & Spinal Tumor
Neurosurgeon, NYU Neurosurgery
Dr. Orringer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 First Ave
Suite 8S, SKI
New York, NY 10016Phone+1 212-263-0909
Education & Training
University of MichiganResidency, Neurological Surgery, 2004 - 2011- University of Michigan Health SystemInternship, Transitional Year, 2004 - 2005
Ohio State University College of MedicineClass of 2004
Certifications & Licensure
NY State Medical License 2019 - 2026
MI State Medical License 2004 - 2022
MA State Medical License 2011 - 2012- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma Start of enrollment: 2020 Oct 28
Publications & Presentations
PubMed
- 320 citationsNear real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networksTodd C. Hollon, Balaji Pandian, Arjun R. Adapa, Esteban Urias, Akshay V. Save
Nature Medicine. 2020-01-06 - 40 citationsArtificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging.Todd Hollon, Cheng Jiang, Asadur Chowdury, Mustafa Nasir-Moin, Akhil Kondepudi
Nature Medicine. 2023-04-01 - 150 citationsNeuronavigation in the surgical management of brain tumors: current and future trendsDaniel A. Orringer, Alexandra J. Golby, Ferenc A. Jolesz
Expert Review of Medical Devices. 2012-09-01
Authored Content
- Recently Viewed (1) Article Information Headings References TrendMD Metrics PubMed Google ScholarNovember 2018
Press Mentions
AI Testing of Brain Tumors Can Detect Genetic Cancer Markers in Less Than 90 Seconds, Study FindsApril 3rd, 2023- DeepGlioma AI Classifies Brain Tumors Within 90 Seconds—and with 93% Accuracy, Study FindsMarch 27th, 2023
- Science News | Study Shows Artificial Intelligence Can Predict Genetics of Cancerous Brain TumorsMarch 26th, 2023
- Join now to see all
Grant Support
- Nanoparticle-Enabled Brain Tumor SurgeryNational Cancer Institute2007–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
